Table 1.
Demographics of the patients between the two groups
| Non-embolization (n=43) | Embolization (n=36) | p-value | |
|---|---|---|---|
| Age (years) | 58.7±13.4 | 56.1±13.6 | 0.395 |
| Sex (M : F) | 30 : 13 | 20 : 16 | 0.192 |
| Primary | |||
| Lung | 16 | 14 | |
| HCC | 7 | 7 | |
| GI | 5 | 4 | |
| Others* | 15 | 11 | |
| Number of instrumented levels | 4.1±1.5 | 3.7±1.3 | 0.177 |
| BMD (T-score) | -2.5±1.1 | -2.3±1.4 | 0.623 |
| ASA grade (1, 2 : 3, 4) | 36 : 7 | 29 : 7 | 0.714 |
| Revised Tokuhashi score | 7.9±2.5 | 6.5±2.2 | 0.111 |
| SINS | 10.4±2.6 | 10.1±3.3 | 0.815 |
Values are presented as mean±standard deviation unless otherwise indicated.
*
Others including hematologic malignancy, breast, uterus, bladder, adrenal gland, hypopharynx, nasopharynx, tongue cancer.
M : male, F : female, HCC : hepatocellular cancer, GI : gastrointestinal, BMD : bone mineral density, ASA : American Society Anesthesiologists physical status classification, SINS : spinal instability neoplastic score